Receive our newsletter – data, insights and analysis delivered to you
In association with Arena International
  1. Sponsored
September 10, 2020updated 18 Nov 2020 7:18pm

Outsourcing in Clinical Trials USA – A Virtual Experience

The Clinical Trials market continues its growth because of increasing R&D expenditure in pharmaceutical and biopharmaceutical companies, globalisation of clinical trials and harmonisation of regulations.

By Victoria Smith


The Clinical Trials market continues its growth because of increasing R&D expenditure in pharmaceutical and biopharmaceutical companies, globalisation of clinical trials and harmonisation of regulations. However, reductions are expected in the growth of this market because of the increasing cost of drug development and clinical trials.

Free Report
img

Improving Clinical Trials

Enter your details here to register for the event and receive your free report. FREE REPORT: How RWS and Clinical Ink Worked Together to Streamline Processes, Drive Efficiency, and Generate Cost-Savings for Clinical Trial Sponsors.
by Arena Healthcare
Enter your details here to receive your free report:

As the industry grapples with unprecedented challenges, join us for the first-ever Outsourcing in Clinical Trials USA virtual experience (30 Sept-1 Oct) brought to you directly in the comfort of your home! Bringing together experts from across the USA to discuss the latest innovations in outsourcing, technology, regulatory affairs and medical devices, this virtual conference will deliver cutting-edge content on how best to manage outsourcing strategies.

REGISTER NOW

It is becoming clear that the only options are to disrupt or be disrupted: and so this event is focused on examining real-world evidence into innovations and industry trends that you cannot afford to miss.

The event will discuss:

  • Drug Development Trends and their Impact on Clinical Trial Execution, Ken Getz, Deputy Director, Research Professor (PCHM), Centre for the Study of Drug Development, Tufts University
  • Exploring How Best to Manage a Shifting Portfolio, Kristine Koontz, Head of US Clinical Operations, GSK
  • Site engagement during the site feasibility process and the impact on study start-Up timelines, Sandeep Menon, Senior Vice President and Head of Early Clinical Development, Pfizer

Our two-day event will be fully online and free to attend, allowing you to connect with others across the industry. Visit our website to learn more about the event and book your place now!

Content from our partners
Clinical Evaluation Report template: a free resource for medical device manufacturers
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Free Report
img

Improving Clinical Trials

Enter your details here to register for the event and receive your free report. FREE REPORT: How RWS and Clinical Ink Worked Together to Streamline Processes, Drive Efficiency, and Generate Cost-Savings for Clinical Trial Sponsors.
by Arena Healthcare
Enter your details here to receive your free report:

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU